Showing results (1681-1690 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|January 18, 2018
Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis?Valeria Rios Rodriguez, Maria Llop, Denis PoddubnyyImmunotherapy|May 16, 2022
Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8+ T cells in lung cancerYanxia Liu, Tongmei Zhang, Lina Zhang, et al.Immunotherapy|July 21, 2021
Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature reviewAaron T Ciner, Howard S Hochster, David A August, et al.Immunotherapy|June 29, 2021
Checkpoint inhibitors in BCG-unresponsive nonmuscle invasive bladder cancer: can they help spare the bladder?Khalil El Gharib, Eddy Lilly, Roy ChebelImmunotherapy|June 30, 2021
Pretreatment lung immune prognostic index as a biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumabAntonello Veccia, Vincenzo Sforza, Emanuela Vattemi, et al.Immunotherapy|June 30, 2021
Immunotherapy for cholangiocarcinoma: a 2021 updateNikolaos Charalampakis, Georgios Papageorgiou, Sergios Tsakatikas, et al.Immunotherapy|June 3, 2021
Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysisEkaterina Laukhtina, Keiichiro Mori, Hadi Mostafaei, et al.Immunotherapy|April 7, 2020
Ipilumumab for hepatocellular cancer in a liver transplant recipient, with durable response, tolerance and without allograft rejectionAbhishek Pandey, Deirdre J CohenImmunotherapy|January 7, 2020
Safety evaluation of a multiallergen immunotherapy treatment in polyallergic patients. APOLO observational studyPilar Alba, Victoria Moreno, José Arias-Irigoyen, et al.Immunotherapy|April 3, 2020
Anifrolumab in systemic lupus erythematosus: current knowledge and future considerationsErik Anderson, Richard FuriePageof 190